Page last updated: 2024-11-04

vorinostat and Vitreoretinopathy, Proliferative

vorinostat has been researched along with Vitreoretinopathy, Proliferative in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Vitreoretinopathy, Proliferative: Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Noh, SJ1
Jeong, WJ1
Rho, JH1
Shin, DM1
Ahn, HB1
Park, WC1
Rho, SH1
Soung, YH1
Kim, TH1
Park, BS1
Yoo, YH1

Other Studies

1 other study available for vorinostat and Vitreoretinopathy, Proliferative

ArticleYear
Sensitization of RPE cells by alphaB-crystallin siRNA to SAHA-induced stage 1 apoptosis through abolishing the association of alphaB-crystallin with HDAC1 in SC35 speckles.
    Investigative ophthalmology & visual science, 2008, Volume: 49, Issue:11

    Topics: alpha-Crystallin B Chain; Apoptosis; Blotting, Western; Cell Count; Cells, Cultured; DNA; Down-Regul

2008